FOURTH AMENDMENT TO LICENSE AGREEMENTLicense Agreement • May 10th, 2016 • Tokai Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMay 10th, 2016 Company IndustryThis Fourth Amendment to License Agreement (“Fourth Amendment”) is effective as of the date of the last signature on the signature page hereto and is between the UNIVERSITY OF MARYLAND, BALTIMORE (“UMB”), a constituent institution of the University System of Maryland, a public corporation and an instrumentality of the State of Maryland, and TOKAI PHARMACEUTICALS, INC., a Delaware corporation (“Company”). Company and UMB are referred to collectively as the “Parties” and each as a “Party.”